A detailed history of Jones Financial Companies Lllp transactions in Exact Sciences Corp stock. As of the latest transaction made, Jones Financial Companies Lllp holds 7,193 shares of EXAS stock, worth $411,799. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,193
Previous 3,863 86.2%
Holding current value
$411,799
Previous $163,000 200.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$42.43 - $70.83 $141,291 - $235,863
3,330 Added 86.2%
7,193 $489,000
Q2 2024

Aug 14, 2024

BUY
$41.33 - $74.26 $136,017 - $244,389
3,291 Added 575.35%
3,863 $163,000
Q1 2024

May 14, 2024

BUY
$56.27 - $73.77 $30,554 - $40,057
543 Added 1872.41%
572 $39,000
Q4 2023

Feb 13, 2024

BUY
$59.06 - $75.72 $1,712 - $2,195
29 New
29 $2,000
Q2 2021

Aug 12, 2021

SELL
$93.66 - $139.27 $2,903 - $4,317
-31 Closed
0 $0
Q1 2021

Apr 30, 2021

BUY
$116.57 - $155.01 $3,613 - $4,805
31 New
31 $4,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.1B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Jones Financial Companies Lllp Portfolio

Follow Jones Financial Companies Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.